Literature DB >> 27396337

Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.

Robert Lesurf1, Miriam Ragle Aure2, Hanne Håberg Mørk3, Valeria Vitelli4, Steinar Lundgren5, Anne-Lise Børresen-Dale2, Vessela Kristensen6, Fredrik Wärnberg7, Michael Hallett8, Therese Sørlie9.   

Abstract

Breast cancer consists of at least five main molecular "intrinsic" subtypes that are reflected in both pre-invasive and invasive disease. Although previous studies have suggested that many of the molecular features of invasive breast cancer are established early, it is unclear what mechanisms drive progression and whether the mechanisms of progression are dependent or independent of subtype. We have generated mRNA, miRNA, and DNA copy-number profiles from a total of 59 in situ lesions and 85 invasive tumors in order to comprehensively identify those genes, signaling pathways, processes, and cell types that are involved in breast cancer progression. Our work provides evidence that there are molecular features associated with disease progression that are unique to the intrinsic subtypes. We additionally establish subtype-specific signatures that are able to identify a small proportion of pre-invasive tumors with expression profiles that resemble invasive carcinoma, indicating a higher likelihood of future disease progression.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27396337     DOI: 10.1016/j.celrep.2016.06.051

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  32 in total

1.  Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity.

Authors:  Tyler Risom; Xiaoyan Wang; Juan Liang; Xiaoli Zhang; Carl Pelz; Lydia G Campbell; Jenny Eng; Koei Chin; Caroline Farrington; Goutham Narla; Ellen M Langer; Xiao-Xin Sun; Yulong Su; Colin J Daniel; Mu-Shui Dai; Christiane V Löhr; Rosalie C Sears
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

2.  Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions.

Authors:  Helga Bergholtz; Tonje G Lien; David M Swanson; Arnoldo Frigessi; Maria Grazia Daidone; Jörg Tost; Fredrik Wärnberg; Therese Sørlie
Journal:  NPJ Breast Cancer       Date:  2020-06-17

3.  Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.

Authors:  Carlos R Gil Del Alcazar; Sung Jin Huh; Muhammad B Ekram; Anne Trinh; Lin L Liu; Francisco Beca; Xiaoyuan Zi; Minsuk Kwak; Helga Bergholtz; Ying Su; Lina Ding; Hege G Russnes; Andrea L Richardson; Kirsten Babski; Elizabeth Min Hui Kim; Charles H McDonnell; Jon Wagner; Ron Rowberry; Gordon J Freeman; Deborah Dillon; Therese Sorlie; Lisa M Coussens; Judy E Garber; Rong Fan; Kristie Bobolis; D Craig Allred; Joon Jeong; So Yeon Park; Franziska Michor; Kornelia Polyak
Journal:  Cancer Discov       Date:  2017-06-26       Impact factor: 39.397

Review 4.  Ductal carcinoma in situ of breast: update 2019.

Authors:  Sunil S Badve; Yesim Gökmen-Polar
Journal:  Pathology       Date:  2019-08-28       Impact factor: 5.306

5.  Wherein the authors attempt to minimize the confusion generated by their study "Breast cancer mortality after a diagnosis of ductal carcinoma in situ" by several commentators who disagree with them and a few who don't: a qualitative study.

Authors:  S A Narod; H Ahmed; V Sopik
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

Review 6.  Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic Management.

Authors:  Shelby Lynn Hophan; Olena Odnokoz; Huiping Liu; Yuan Luo; Seema Khan; William Gradishar; Zhuan Zhou; Sunil Badve; Mylin A Torres; Yong Wan
Journal:  Endocrinology       Date:  2022-04-01       Impact factor: 4.736

Review 7.  Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ.

Authors:  Bethany N Hannafon; Wei-Qun Ding
Journal:  Am J Pathol       Date:  2018-09-29       Impact factor: 4.307

8.  Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.

Authors:  Xavier Tekpli; Vessela N Kristensen; Miriam Ragle Aure; Thomas Fleischer; Sunniva Bjørklund; Jørgen Ankill; Jaime A Castro-Mondragon; Anne-Lise Børresen-Dale; Jörg Tost; Kristine K Sahlberg; Anthony Mathelier
Journal:  Genome Med       Date:  2021-04-29       Impact factor: 11.117

9.  Expression Analysis of Long Non-Coding RNAs Related With FOXM1, GATA3, FOXA1 and ESR1 in Breast Tissues.

Authors:  Bita Hassani; Mohammad Taheri; Yazdan Asgari; Ali Zekri; Ali Sattari; Soudeh Ghafouri-Fard; Farkhondeh Pouresmaeili
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

10.  Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression.

Authors:  Haifeng Xu; Tonje Lien; Helga Bergholtz; Thomas Fleischer; Lounes Djerroudi; Anne Vincent-Salomon; Therese Sørlie; Tero Aittokallio
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.